Stemina Biomarker Discovery

    OverviewSuggest Edit

    Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers. It offers devTOX quickPredict, a screening service that uses human embryonic or induced pluripotent stem cells to screen drug candidates, chemicals, consumer products, and cosmetics for their potential effect on the developing human embryo. The company also focuses on the diagnosis and treatment of neurological disorders.
    TypePrivate
    Founded2006
    Websitestemina.com

    Latest Updates

    Employees (est.) (Mar 2020)15(-11%)

    Stemina Biomarker Discovery Financials and Metrics

    Summary Metrics

    Founding Date

    2006

    Stemina Biomarker Discovery latest funding size

    $1 m
    Show all financial metrics

    Stemina Biomarker Discovery Online and Social Media Presence

    Embed Graph

    Stemina Biomarker Discovery Frequently Asked Questions

    • When was Stemina Biomarker Discovery founded?

      Stemina Biomarker Discovery was founded in 2006.

    • How many employees does Stemina Biomarker Discovery have?

      Stemina Biomarker Discovery has 15 employees.

    • Who are Stemina Biomarker Discovery competitors?

      Competitors of Stemina Biomarker Discovery include NanoView Biosciences, Entegrion and Assertio Therapeutics.